Envestnet Portfolio Solutions Inc. Grows Position in The Clorox Company (NYSE:CLX)

Envestnet Portfolio Solutions Inc. boosted its position in The Clorox Company (NYSE:CLX - Free Report) by 17.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,755 shares of the company's stock after buying an additional 3,873 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in Clorox were worth $4,183,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CLX. Brooklyn Investment Group boosted its holdings in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of Clorox in the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC boosted its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after buying an additional 138 shares in the last quarter. Asset Planning Inc acquired a new position in Clorox during the fourth quarter worth $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new position in Clorox in the fourth quarter worth $36,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Down 0.3 %

CLX traded down $0.46 during trading on Friday, hitting $144.88. The company's stock had a trading volume of 1,553,392 shares, compared to its average volume of 1,211,967. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The firm's 50 day moving average price is $152.84 and its 200-day moving average price is $159.78. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a market cap of $17.85 billion, a PE ratio of 39.58, a PEG ratio of 2.62 and a beta of 0.45.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the company earned $2.16 earnings per share. On average, analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.37%. Clorox's payout ratio is 133.33%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CLX. Barclays upped their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Wells Fargo & Company upped their target price on Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Finally, Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.